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CHAPTER I 
 
 
INTRODUCTION 
 
 
The relationship between fungi and humans has a long and complex history.  
While certain varieties of mushrooms and yeast have served as food sources for 
millennia, many fungi produce harmful secondary metabolites known as mycotoxins.  
The earliest accounts of mycotoxicosis involve the infamous syndrome “ergotism”, 
caused by ergot alkaloids in crops contaminated with Claviceps purpurea mold1.  While 
the ergot alkaloids and most other mycotoxins are not carcinogenic, several 
carcinogenic mycotoxins have recently been identified.  Among these are aflatoxin, 
luteoskyrin2, and sterigmatocystin3.   
 Aflatoxin was discovered in the 1960’s when the widespread hepatotoxicity 
observed in poultry in the United Kingdom was traced back to ground-nut meal 
contaminated with Aspergillus flavus mold1.  Soon after this finding, A. flavus mold was 
implicated in an outbreak of liver cancer among hatchery-reared rainbow trout4.  
Subsequent laboratory experiments showed that rats fed the contaminated meal 
developed liver cancer, providing the first evidence for the existence of carcinogenic 
mycotoxins1.   
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 Hepatotoxicity has also been documented in humans following aflatoxin 
exposure.  Consumption of 2-6 mg aflatoxin daily for a month or longer leads to acute 
aflatoxicosis, characterized by jaundice, portal hypertension, and ascites5.  Far more 
common, however, is long-term exposure to lower levels of aflatoxin, which is 
implicated in the high rates of hepatocellular carcinoma seen in some developing 
countries6.  Accordingly, aflatoxin has been classified as a Group 1 carcinogen in 
humans7.  There is a synergistic relationship between aflatoxin exposure and hepatitis B 
infection, both of which are prevalent in many developing countries.  The risk of liver 
cancer is doubled by chronic aflatoxin exposure and quintupled by hepatitis B infection.   
However, the combination of chronic aflatoxin exposure and hepatitis B infection leads 
to an alarming sixtyfold increase in the rate of liver cancer8. 
Four toxic compounds have been isolated from A. flavus (Figure 1).  All share a 
common difuranocoumarin moiety.  Named according to their chromatographic 
properties, aflatoxin B1 (AFB1) and aflatoxin B2 (AFB2) fluoresce blue, while aflatoxin G1 
(AFG1) and aflatoxin G2 (AFG2) fluoresce green
1.  Of these, AFB1 is of the greatest 
concern to human health.  AFB1 is not only highly genotoxic, but it is also the most 
commonly found aflatoxin in food.   
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Figure 1.  The structures of aflatoxins B1, B2, G1, and G2.  
 
Early experiments demonstrated that the metabolism of AFB1 is integral to its 
mutagenicity.  While treatment of nucleic acid with AFB1 results in a reversible nucleic 
acid-carcinogen complex9, coincubation of monooxygenases with nucleic acid and AFB1 
leads to the covalent DNA adduct1.  Incubation of Salmonella typhimurium with AFB1 
and a rat liver preparation leads to bacterial killing, but this killing effect could be 
blocked by the addition of exogenous nucleic acid or CYP450 inhibitors to the assay.  The 
nucleic acids in this assay were found to be covalently bound to the AFB1 metabolite
1. 
The structure of AFB1 led researchers to envision the 8,9-epoxide (Figure 2) as the 
ultimate carcinogen10.  While the epoxide has never been directly observed in biological 
systems, likely due to its half-life of less than ten seconds in aqueous solution11, its 
existence has been confirmed by indirect means.  For example, acid hydrolysis of AFB1-
DNA adducts yields AFB1-8,9-dihydrodiol, a product consistent with the proposed 
epoxide12.   
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Figure 2.  Structure of AFB1-exo-8,9-epoxide. 
 
Early attempts to prepare the epoxide in vitro were unsuccessful.  Synthetic 
attempts have included oxidation by m-chloroperbenzoic acid13, sensitized 
photooxidation14, and solvolysis of 8-(acyloxy)-9-hydroxy AFB1 derivatives
15.  These 
methods failed largely because of acidic or nucleophilic components of the reaction 
mixture causing cleavage of the epoxide16.  The ultimate carcinogen, AFB1-exo-8,9-
epoxide, was finally prepared by DMDO oxidation11 (Figure 3). 
 
 
 
Figure 3.  Preparation of AFB1-exo-8,9-epoxide by DMDO oxidation of AFB1 in 
dichloromethane. 
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AFB1 epoxide is highly genotoxic.  Over half of hepatocellular carcinoma cases 
resulting from aflatoxin exposure are associated with a G to T mutation at the third 
position of codon 249 in the p53 gene17.  Similar G to T mutations in the first and second 
positions of codon 12 in the Ha-ras protooncogene are also likely to be involved in 
tumorogenicity18.  Binding occurs preferentially at CpG islands19.  Site-specific 
mutagenesis assays reveal AFB1-induced G→T transversions at a level of 5% in E. coli
20.  
The major adduct in vitro is trans-8,9-dihydro-(N7-guanyl)-9-hydroxy AFB1 (Figure 3)
12.  
DNA is thermodynamically stabilized by the adduct21. 
 
 
Figure 4.  Structure of trans-8,9-dihydro-(N7-guanyl)-9-hydroxy AFB1. 
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The AFB1-N7-dG adduct may either depurinate to yield an abasic site, or hydrolyze to 
the formamidopyrimidine (FAPY) adduct22.  The FAPY derivative results from opening of 
the imidazole ring of the initial cationic adduct12.  While the β anomer is favored in 
duplex DNA, there is a 2:1 α:β mixture in single-stranded DNA23.  The α anomer blocks 
replication and the β anomer is mutagenic23.  In fact, the AFB1-β-FAPY adduct causes 
G→T transversions at levels up to 36%, which is six times as mutagenic as the cationic 
adduct24.  The overall reaction pathway for AFB1 is summarized below (Figure 5). 
 
 
Figure 5.  Summary of AFB1 metabolism. 
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The stereospecificity of the reaction suggests that AFB1 epoxide is held in a reaction-
promoting orientation upon its association with DNA.  An intercalated transition state 
with the epoxide positioned above the 5’ face of dG would facilitate nucleophilic attack 
by N721.  The planar difuranocoumarin structure of AFB1 alone is suggestive of 
intercalation. In agreement with this hypothesis, molecular modeling studies have 
demonstrated intercalation of AFB1 in DNA
25.  Furthermore, binding of AFB1 to DNA 
causes increased proton shielding21.  Later studies confirmed intercalation of the 
mutagen above the 5’ face of dG by NMR.  Interestingly, the sterigmatocystin adduct 
adopts a similar intercalated structure26. 
Intercalation is responsible for the differential stoichiometry of the reactions of AFB1 
with certain oligonucleotide sequence isomers.  Only one equivalent of epoxide can 
react with d(ATCGAT), while two equivalents of epoxide can react with d(ATGCAT).  This 
difference in stoichiometry is due to intercalation of the epoxide above the 5’ face of 
dG, which precludes binding of another AFB1 equivalent to the complementary strand in 
d(ATCGAT) but leaves open a second binding site in d(ATGCAT)21.   
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Due to the fact that AFB1 epoxide binds preferentially at CpG islands, which are 
frequently methylated27, it is important to know the chemistry of the reaction between 
AFB1 epoxide and methylated DNA sequences.  Therefore, the current work aims to 
describe the reaction between AFB1 epoxide and the methylated sequence isomers 
d[AT(5-methyl-dC)GAT]2 and d[ATG(5-methyl-dC)AT]2, as well as the hydroxymethylated 
sequence isomers d[AT(5-hydroxymethyl-dC)GAT]2 and d[ATG(5-hydroxymethyl-
dC)AT]2.  Each sequence was reacted with a molar excess of AFB1 epoxide.  The limiting 
stoichiometry was determined for each sequence by high performance liquid 
chromatography (HPLC).     
The reactions of AFB1 with d[AT(5-methyl-dC)GAT]2 and d[AT(5-hydroxymethyl-
dC)GAT]2 reached equilibrium after only half of the strands had reacted, as predicted by 
the 1:1 stoichiometry of the unmodified sequence.  In contrast, the reactions of AFB1 
with d[ATG(5-methyl-dC)AT]2 and d[ATG(5-hydroxymethyl-dC)AT]2 reached equilibrium 
after all of the strands had reacted, as predicted by the 2:1 stoichiometry of the 
unmodified sequence.  These findings suggest that methylation and hydroxymethylation 
do not influence the equilibrium conditions for the reaction between AFB1 epoxide and 
these sequence isomers. 
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CHAPTER II 
 
 
METHODS 
 
 
Synthesis of Dimethyldioxirane (DMDO) 
DMDO was prepared by fractional distillation as a 0.025 M solution in acetone28.  
A fractional distillation apparatus was assembled and equipped with separate 
attachments for adding solid and liquid.  NaHCO3 (16 g, 0.20 mol) was added to a 250 
mL distilling flask.  KHSO5 (30 g, 0.20 mol) was added to the solid addition attachment 
and 50 mL of a 1:1 mixture of water and acetone was added to the liquid addition 
attachment.  The entire apparatus was placed under a nitrogen atmosphere and cooled 
to -78°C in a dry ice/acetone bath.  The KHSO5 was added slowly over a period of 15 
minutes, then the reaction was allowed to proceed for another 20 minutes.  The liquid 
in the receiving flask was removed and stored over anhydrous MgSO4 at -4°C.  
Formation of DMDO was confirmed by NMR spectroscopy by placing ten µL of the 
solution combined with 600 µL of dry deuterated chloroform in a 5mm NMR tube.  A 1H 
NMR spectrum was obtained on a 500 MHz Bruker NMR spectrometer.  The 
concentration of DMDO was determined by comparing the height of the methyl peak to 
the height of the 13C satellite peak of acetone. 
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Synthesis of Aflatoxin B1 Epoxide (AFB1) 
Aflatoxin B1 is extremely hazardous due to its carcinogenicity and should be 
handled using appropriate safety procedures.  All reactions were conducted in a well-
ventilated hood using disposable latex gloves.  Afterwards, the work area was bleached 
with NaOCl solution.   
DMDO (10.5 µmol) was added to AFB1 (10 mg, 7.0 µmol) dissolved in 0.5 mL 
dichloromethane.  After 20 minutes, excess DMDO solution was removed by 
evaporation under a stream of nitrogen gas.  One mg of the product was dissolved in 
600 µL of dry deuterated chloroform and added to a 5mm NMR tube.  A 1H NMR 
spectrum was obtained on a 500 MHz Bruker NMR spectrometer.  The remaining 
epoxide was stored at -4°C. 
Preparation of AFB1 DNA Adducts 
The oligonucleotides 5’-ATCGAT-3’, 5’-ATGCAT-3’, 5’-AT(5-methyl-dC)GAT-3’, 5’-ATG(5-
methyl-dC)AT-3’, 5’-AT(5-hydroxymethyl-dC)GAT-3’, and 5’-ATG(5-hydroxymethyl-
dC)AT-3’ were synthesized by Midland Certified Reagent Company.  The purity of the 
samples was confirmed using HPLC and the mass of the oligonucleotides was confirmed 
by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-
TOF).   
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AFB1 epoxide (1 mg, 3 µmol) was dissolved in 0.2 mL dichloromethane and 
added to the oligonucleotide (0.36 µmol) dissolved in 0.2 mL buffer (10 mM sodium 
phosphate dibasic, 100 mM sodium chloride, 10 mM magnesium chloride, 0.05 mM 
ethylenediaminetetraacetic acid).  The mixture was stirred at 5°C for 30 min.  The 
aqueous layer was collected and analyzed by HPLC.   
High-Performance Liquid Chromatography 
 The sample was dissolved in water and a glass syringe was used to inject 200 
nmol of the sample onto a 5 micron Phenomenex 250 x 10 mm column attached to a 
Beckman Coulter HPLC.  All samples were run in acetonitrile and 0.1 M ammonium 
formate buffer, adjusted to pH 7.2 by titration with 5 M NaOH.  The HPLC gradient was 
as follows: acetonitrile remained at 5% from 0 to 5 min, slowly raised to 16% from 5 to 
60 min, slowly dropped back down to 5% from 60 to 65 min, then kept constant at 5% 
from 65 to 70 min.  Absorbance was read at 254 nm and 360 nm.  The area under the 
peaks was used to determine the ratio of unreacted oligonucleotide (absorbs at 254 nm) 
to the adduct (absorbs at both 254 nm and 360 nm).   
Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry 
 Ten µL of 3-hydroxypicolinic acid (0.5 M in 50/50 acetonitrile/water), 5 µL of 
ammonium citrate (0.1 M in 50/50 acetonitrile/water), and 3 nmol of DNA in 1 µL water 
were added to a vial.  One µL of the mixture was added to a 96 well MALDI plate and 
allowed to dry.  The MALDI spectrum was obtained in negative ion mode on a Voyager-
DE STR MALDI mass spectrometer.   
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CHAPTER III 
 
RESULTS 
 
Dimethyldioxirane 
 The 1H NMR spectrum of DMDO showed a diagnostic methyl peak at 1.65 ppm  
(Figure 6).  The concentration of DMDO was calculated by comparing the height of the 
methyl peak to the height of the 13C satellite peak of acetone at 1.95 ppm.    
 
Figure 6.  1H NMR spectrum of DMDO. 
 
AFB1 Epoxide 
The 1H NMR spectrum of aflatoxin B1 epoxide showed diagnostic epoxide peaks 
at 3.5 and 5.4 ppm (Figure 7).   
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Figure 7.  1H NMR spectrum of aflatoxin B1 epoxide. 
 
ATCGAT-AFB1 
 ATCGAT was analyzed before and after reaction with AFB1 epoxide (Figure 8).  
Pure ATCGAT gave a single large peak at 34 min.  After the reaction, two peaks were 
observed at 34 min (35% intensity) and 53 min (37% intensity).  This finding indicates a 
1:1 AFB1:d(ATCGAT)2 limiting stoichiometry in the formation of the 
d(ATCAFBGAT)·d(ATCGAT) adduct.   
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Figure 8.  ATCGAT before (above) and after (below) reaction with AFB1 epoxide. 
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ATGCAT-AFB1 
 ATGCAT was analyzed before and after reaction with AFB1 epoxide (Figure 9).  
Pure ATGCAT gave a single large peak at 35 min.  After the reaction, two peaks were 
observed at 35 min (7% intensity) and 54 min (69% intensity).  This finding indicates a 
2:1 AFB1:d(ATGCAT)2 limiting stoichiometry in the formation of the d(AT
AFBGCAT)2 
adduct. 
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Figure 9.  ATGCAT before (above) and after (below) reaction with AFB1 epoxide. 
  
AT(5-methyl-dC)GAT-AFB1 
 AT(5-methyl-dC)GAT was analyzed before and after reaction with AFB1 epoxide 
(Figure 10).  Pure AT(5-methyl-dC)GAT gave a single peak at 36 min.  After the reaction, 
two peaks were observed at 35 min (23% intensity) and 54 min (20% intensity).  This 
finding indicates a 1:1 AFB1:d[AT(5-methyl-dC)GAT]2 limiting stoichiometry in the 
formation of the d[AT(5-methyl-dC)AFBGAT)·d[AT(5-methyl-dC)GAT]  adduct.   
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Figure 10.  AT(5-methyl-dC)GAT before (above) and after (below) reaction with AFB1 
epoxide.   
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ATG(5-methyl-dC)AT-AFB1 
 ATG(5-methyl-dC)AT was analyzed before and after reaction with AFB1 epoxide 
(Figure 11).  Pure ATG(5-methyl-dC)AT gave a single peak at 36 min.  After the reaction, 
two peaks were observed at 35 min (2% intensity) and 53 min (58% intensity).  This 
finding indicates a 2:1 AFB1:d[ATG(5-methyl-dC)AT]2 limiting stoichiometry in the 
formation of the d[ATG(5-methyl-dC)AFBAT]2 adduct.   
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Figure 11.  ATG(5-methyl-dC)AT before (above) and after (below) reaction with AFB1 
epoxide. 
 
AT(5-hydroxymethyl-dC)GAT-AFB1 
 AT(5-hydroxymethyl-dC)GAT was analyzed before and after reaction with AFB1 
epoxide (Figure 12).  Pure AT(5-hydroxymethyl-dC)GAT gave a single peak at 34 min. 
After the reaction, two peaks were observed at 34 min (22% intensity) and 52 min (19% 
intensity).  This finding indicates a 1:1 AFB1:d[AT(5-methyl-dC)GAT]2 limiting 
stoichiometry in the formation of the d[AT(5-hydroxymethyl-dC)AFBGAT)·d[AT(5-
hydroxymethyl-dC)GAT]  adduct.  However, there were several peaks in the HPLC trace 
that have not been accounted for. 
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Figure 12.  AT(5-hydroxymethyl-dC)GAT before (above) and after (below) reaction with 
AFB1 epoxide.   
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ATG(5-hydroxymethyl-dC)AT-AFB1 
 ATG(5-hydroxymethyl-dC)AT was analyzed before and after reaction with AFB1 
epoxide (Figure 12).  Pure ATG(5-hydroxymethyl-dC)AT gave a single peak at 36 min.  
After the reaction, two peaks were observed at 36 min (2% intensity) and 55 min (56% 
intensity).  This finding indicates a 2:1 AFB1:d[ATG(5-hydroxymethyl-dC)AT]2 limiting 
stoichiometry in the formation of the d[ATG(5-hydroxymethyl-dC)AFBAT]2 adduct.   
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Figure 13.  ATG(5-hydroxymethyl-dC)AT before (above) and after (below) reaction with 
AFB1 epoxide.   
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CHAPTER IV 
 
DISCUSSION 
 
 The sequence isomers ATCGAT and ATGCAT were selected due to their utility in 
previous studies of AFB1 epoxide reactivity
21.  Since the sequence is self-complementary, 
the task of synthesizing and annealing two different but complementary strands was 
avoided.  Furthermore, palindromic sequences are not susceptible to regioselectivity 
issues that could arise if the two guanines in the duplex were not identical.  The 
placement of cytosine and guanine beside one another was driven by the finding that 5’-
CpG-3’ is the preferred binding site for the epoxide19. 
In agreement with previous work by Gopalakrishnan et al.29, the limiting 
stoichiometry for the reaction between AFB1 epoxide and the oligonucleotide duplex 
was found to be 1:1 for ATCGAT and 2:1 for ATGCAT.  The epoxide intercalates above 
the 5’ face of dG, preventing another equivalent of epoxide from binding to the 
complementary strand of ATCGAT, but not ATGCAT.  Interestingly, methylation and 
hydroxymethylation do not cause the reaction to deviate from this limiting 
stoichiometry.   
24 
 
 While the results approximated the predicted stoichiometry, they did not go to 
completion.  One possible explanation is the formation of hairpin loops, which is not 
uncommon for palindromic sequences such as the ones utilized in this study.  The 
reaction could be optimized by adjusting variables such as pH and salt concentration in 
order to minimize the formation of hairpin loops.   In this reaction, DNA and water 
compete for reaction with AFB1 epoxide.  Even though the reaction with DNA occurs 
rapidly, it is known that the epoxide is hydrolyzed to AFB1-8,9-dihydrodiol in aqueous 
solution.  It is possible that a small portion of the epoxide used in the reaction is 
hydrolyzed to the diol, which could intercalate the oligonucleotide and effectively block 
the epoxide binding site.  This problem could be addressed by extracting the reaction 
mixture in dichloromethane to remove hydrolyzed epoxide and adding another excess 
of fresh epoxide.  The protocol could be further optimized by taking aliquots at different 
times during the reaction to identify the exact point at which equilibrium is reached. 
 While the current work addresses the stoichiometry of the reaction, it does not 
answer the important question of the relative stability of the adducts.  Previous studies 
have shown that AFB1 has a stabilizing effect on DNA
21.  However, the magnitude of this 
effect is unknown for the sequences in this study.  Future work could utilize melting 
experiments to determine the effect of AFB1 on the thermodynamic stability of the 
oligonucleotides.   
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